 |
|
|
|
|
|
|
|
|
|
|
|
 |
|
||||||||||
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
|
||||||
 |
 |
 |
 |
 |
|
||||||
 |
 |
 |
 |
 |
|
||||||
MSC2007 brought together more than 300 attendees from 27 countries and 127 institutions. Take a look back at the 2007 conference program to get an idea of what to expect at MSC2009. More information on the MSC2009 program will be posted as details are finalized.
Want to be involved in the planning and implementation of MSC2009? We welcome volunteers for session chairs, suggestions for speakers, and feedback on topics you'd like to hear about. Contact Michael Gilkey at registration@mscconference.net or 1-216-386-2079 to become a part of MSC2009 today.
MSC2007 • Detailed Program
Quick Links to daily schedule:
Session 1 • Session 2 • Session 3 • Session 4
Session 5 • Session 6 • Session 7 • Session 8
Program and Speakers:
Monday, August 27, 2007
1:15 p.m. Session I: Chronology of Discovery of MSCs
Chair: Stanton Gerson
1:15-1:45 Arnold Caplan “MSCs: Yesterday, Today and Tomorrow”
1:45-2:15 Mark Pittenger “A Paradigm for Understanding Tissue Regeneration: Origins of MSCs"
2:15-2:45 Darwin Prockop “The Repairative Power of Multipotent Stromal Cells from Bone Marrow”
2:45-3:15 Catherine Verfaillie “Possible mechanisms underlying the greater potency of adult stem cells?”
3:15 – Break
3:30 p.m. – Session II: Stem Cells from Bone Marrow
Chair: George Muschler
3:30-4:00 Paolo Bianco “Self-renewing stromal progenitors and the hematopoietic microenvironment in the human bone marrow A tale of two stem cells”
4:00-4:30 Dominique Bonnet “Prospective isolation of the most primitive stem/progenitors in the adult murine bone marrow mesenchymal compartment”
4:30-5:00 Paul Simmons “The Yin and Yang of MSC”
5:00-6:00 p.m. – Short Talk Presentations
Chair: Arnold Caplan
5:00-5:05 Lianhua Bai “Signal Secreted from Human Mesenchymal Stem Cells Regulate Cell Fate Choices by Neural Stem Cells”
5:05-5:10 Antonio Crovace “Use of Autologous Bone Marrow Mononuclear Cells and Cultured Bone Marrow Stromal Cells in Dogs with Orthopedic Lesions”
5:10-5:15 Qian Ye “Characterization of Placenta Derived Adherent Cells (PDAC): a Novel Type of Stem/Progenitor Cell Isolated From Human Placenta”
5:15-5:20 Nicanor Moldovan “Sponstaneously Recurited Bone Marrow Progenitor Cells are Cardogenic and Vaculogenic in Ischemic Myocardium”
5:20-5:25 Maria Siemionow “Contribution of Donor Derived Bone Marrow Stromal Cells and Neurotrophic Factor for Regeneration of Peripheral Nerve Defects”
5:25-5:30 Anita Laitinen “Mesenchymal Stem Cells from Umbilical Cord Blood in Low Serum Conditions”
5:30-5:35 Noelle Mathieu “Human Mesenchymal Stem Cell Favour Healing of Cutaneous Radiation Syndrome”
5:35-5:40 Tomoyuki Okumura “Identification of a Specific Bone Marrow-Derived Cell Subset that Contributes to the Gastric Epitheluim”
5:40-5:45 Cecilia Sanchez “Global Epigenetics Changes in Human Multipotential Stromal Cells (hMSCs) During Culture”
5:45-5:50 Graham Sharp “Multipotential Mesenchymal Stromal Cells Improve Survival in a Murine Model of Graft-Versus-Host Disease”
5:50-5:55 Vladimir Smirnov “Circulating Stromal Colony-Forming Units and Coronary Atherosclerosis”
5:55-6:00 Joni Ylostalo “Human Multipotent Stromal Cells (MSCs) Repeatedly Create Their Own Microenvironments as they are Expanded and Re-expanded from Single Cells into Colonies”
6:00-9:00 p.m. – Poster Session with Heavy Hors D'oeuvres and Bar Service.
• to top of page • back to program •
7:00 a.m. – Breakfast
8:00 a.m. – Session III: Stem Cells from Adipose Tissue
Chair: Mark Pittenger
8:00-8:30 Marc Hedrick “Adipose tissue: A promising source of cells for cell-based therapies”
8:30-9:00 Farshid Guilak “Adipose-derived stem cells for cartilage tissue engineering”
9:00-9:30 Jan Nolta “Tracking Human Adipose-Derived Mesenchymal Stem Cells for Tissue Repair Applications in Immune Deficient Mouse Xenotransplantation Models”
Platform Presentations:
9:30-9:45 Reza Izadpanah “In Vivo Neurogenesis Potentials of Adult Mesenchymal Stem Cells”
9:45-10:00 Jeff Thompson “Differentiation of Human Adult Adipose-Derived Mesenchymal Stem Cells into Adipocytes, Osteocytes, and Neurons In Vitro”
10:00 a.m. – Break
10:15 a.m. – Session IV: Stem Cells from Cord Blood/Placenta
Chair: Pablo Rubinstein
10:15-10:45 Wolfgang Hofgartner “Placenta Derived Adherent Cells (PDACs): A Novel Type of Stem/Progenitor Cell Isolated from Human Placenta”
10:45-11:15 Peter Wernet “TBD"
Podium Presentations:
11:15-11:30 Jane Ennis “Human Umbilical Cord Perivascular Cells are Immunoprivileged and Immunomodulatory In Vitro”
11:30-11:45 Maria Roubelakis “Human Mesenchymal Stem Cells (MSCs) Derived from Amniotic Fluid: Proteomic Characterization & Differentiation Potential”
11:45-12:15 Anthony Atala “Regenerative Medicine: New Approaches in Health Care for the 21st Century"
12:15 p.m. – Lunch Discussion "Terminology For Adult Derived Stem Cells"
Chair: Anthony Atala
Mark Pittenger
Paolo Bianco
Marc Hedrick
Catherine Verfaillie
1:30 p.m. – Session V: Trophic Pathways and Expression
Chair: Mahendra Rao
1:30-2:00 Marc Penn “Paracrine effects of improvement in cardiac function following stem cell therapy”
2:00-2:30 Luis Solchaga “FGF-treated hMSCs exhibit enhanced proliferation and differentiation potential”
Podium Presentations:
2:30-2:45 Arshak Alexanian “Transplanted Neurally Induced Mesenchymal Stem Cells Survive, Generate Neuronal and Glial Cells, and Integrate into Intact Spinal Cord of Rats”
2:45-3:00 Humberto Cerruti “Allogenous Bone Grafts improved by Bone Marrow Stem Cells and Platelet Growth Factors: Clinical Case Reports”
3:00-3:15 Keith Haskell “A RNAI Screen to Identify Genes that Regulate the Osteogenic, Adipogenic, and Prolifeative Capacities of Human Mesenchymal Stem Cells”
3:15-3:30 Biju Parekkadan “Bone Marrow Stroma-Derived Molecules Reverse Organ Failure”
3:30 p.m. – Break
3:45 p.m. – Session VI: Tissue Engineering and Animal Models
Chair: Stanley Dannemiller
3:45-4:15 Frank Barry “Cell Therapy for Musculoskeletal Repair: Cells and Differentiation"
4:15-4:45 Robert Harman “Veterinary Cell Therapy: Real Data from Real Diseases”
5:15-5:45 Alan Trounson “Stem Cell Repair of Lung Disease”
Podium Presentations:
5:45-6:00 Bruno Peault “Pervascular Cells as Ancestors of Mesenchymal Stem Cells in Human Tissues”
6:00-6:15 Manu Platt “Cue-Signal-Response Analysis of Mesenchymal Stem Cell Adhesion and Survival Behavior on Ligan-Coated Scaffolds”
6:15-6:30 Alexandra Semont “Structural and Functional Small Intestine Regeneration after Mesenchymal Stem Cell Infusion”
6:30 p.m. – Poster Session with Hors D'oeuvres and Bar Service
7:00 p.m. – Keynote Lecture by Linda Powers with Hors D'oeuvres and Bar Service
8:00 p.m. – Banquet
• to top of page • back to program •
7:00 a.m. – Breakfast
8:15 a.m. – Session VII: Therapeutic Applications
Chair: Alan Smith
8:15-8:45 Katarina LeBlanc “Mesenchymal Stem Cells (MSCs) in Immunotherapy”
8:45-9:15 Armand Keating “Mesenchymal Stromal Cells (MSCs) for Cardiac Regeneration: Development of a Unique Cell Type Characterized by Plasticity and not Transdifferentiation”
9:15-9:45 Robert Miller “Use of MSCs for the Treatment of Demyelinating Diseases”
Podium Presentations:
9:45-10:00 Paulette Conget “Adult Allogeneic MSC IN UTERO Transplantation to Human Fetuses with Severe Bone Pathology Lead to No Postnatal Fractures: 2 Cases Treated in Chile”
10:00-10:15 Frank Marini “Low-Dose Local Irradiation Increases Migration and Recruitment of Circulating MSC Into Tumor Microenvironment”
10:15 a.m. – Break
10:30 a.m. – Session VIII: Clinical Trials
Chair: Robert Deans
10:30-11:00 Keith Wonnacott "A Regulatory Perspective on Developing Mesenchymal Stem Cell Therapies"
11:00-11:30 Hillard Lazarus “Current and Future Clinical Trial Strategies for Managing GVHD in Hematopoietic Stem Cell (HSC) Transplantation”
11:30-12:00 Michael Chopp “Preclinical Applications of MSCs to Neurological Diseases—Long Term Benefits and Mechanisms of Action”
12:00-12:30 C. Randal Mills “Introduction to Osiris’ Clinical Programs”
12:30 p.m.– Closing Remarks: Arnold Caplan
